ScopeUniversitätsklinikum Schleswig-Holstein (UKSH) Institut für Humangenetik
77 capabilities
Accredited since January 2026
Verified Oct 2026
One of 3,209 in Germany
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Ratzeburger Allee 160
Lübeck 23538 , Germany
Lübeck 23538 , Germany
Accreditation
Active
DAkkS
D-ML-13069-18-01
Specialises in human genetics testing including chromosome analysis, CNV analysis, and related molecular investigations on blood, tissue, and cellular samples. The laboratory operates under flexible accreditation permitting procedure development and modification.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13069-18-01
Status
ActiveSince
29 January 2026
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFAdditional scope documents
Test Capabilities (77)
| Standard Reference | Description | Category |
|---|---|---|
| Angeborener Chromosomensatz | angeborener Chromosomensatz | Biocompatibility (ISO 10993) |
| Erworbener Chromosomensatz | erworbener Chromosomensatz | Biocompatibility (ISO 10993) |
| (AR) | SBMA (AR) | Food Safety Testing |
| (HTT) | Huntington (HTT) | Food Safety Testing |
| Aderhautmelanom, erblich (BAP1, MBD4), SNV | Aderhautmelanom, erblich (BAP1, MBD4), SNV | Food Safety Testing |
| Adrenogenitale Syndrom (CYP11A1, STAR, HSD3B2, CYP17A1, CYP11B1, POR), , SNV | Adrenogenitale Syndrom (CYP11A1, STAR, HSD3B2, CYP17A1, CYP11B1, POR), , SNV | Food Safety Testing |
| Albinismus (TYR, OCA2, TYRP1, SLC45A2, SLC24A5) | Albinismus (TYR, OCA2, TYRP1, SLC45A2, SLC24A5) | Food Safety Testing |
| Albinismus (TYR, OCA2, TYRP1, SLC45A2, SLC24A5), , SNV | Albinismus (TYR, OCA2, TYRP1, SLC45A2, SLC24A5), , SNV | Food Safety Testing |
| DRPLA (ATN1) | DRPLA (ATN1) | Food Safety Testing |
| FLT3 (TKD, ITD), CEBPA, TP53, ASXL1, BCOR, EZH2, RUNX1, SF3B1, SRSF2, STAG2, U2AF1, ZRSR2, IDH1 | FLT3 (TKD, ITD), CEBPA, TP53, ASXL1, BCOR, EZH2, RUNX1, SF3B1, SRSF2, STAG2, U2AF1, ZRSR2, IDH1 | Food Safety Testing |
| FMR1) | Fra(X)-Syndrom, FXTAS (FMR1) | Food Safety Testing |
| Friedreich Ataxie (FXN) | Friedreich Ataxie (FXN) | Food Safety Testing |
| Huntington-like (TBP, JPH3) | Huntington-like (TBP, JPH3) | Food Safety Testing |
| (CYP21A2) | 21-Hydroxylasemangel (CYP21A2) | Molecular Diagnostics / PCR |
| (GJB2 ) | Schwerhörigkeit (GJB2) | Molecular Diagnostics / PCR |
| (SF3B1, TP53, NPM1, FLT3 (TKD, ITD), ASXL1, BCOR, CBL, DNMT3A, ETV6, EZH2, IDH1, IDH2, KRAS, NRAS, RUNX1, SETBP1, SRSF2, STAG2, U2AF1 und TET2), SNV | (SF3B1, TP53, NPM1, FLT3 (TKD, ITD), ASXL1, BCOR, CBL, DNMT3A, ETV6, EZH2, IDH1, IDH2, KRAS, NRAS, RUNX1, SETBP1, SRSF2, STAG2, U2AF1 und TET2), SNV | Molecular Diagnostics / PCR |
| (SHOX ) | Kleinwuchs (SHOX) | Molecular Diagnostics / PCR |
| (STK11) | Peutz-Jeghers-Syndrom (STK11) | Molecular Diagnostics / PCR |
| (TP53), SNV | (TP53), SNV | Molecular Diagnostics / PCR |
| (TP53, NRAS, KRAS, BRAF, BIRC3, JAK3, PDGFRA), SNV | (TP53, NRAS, KRAS, BRAF, BIRC3, JAK3, PDGFRA), SNV | Molecular Diagnostics / PCR |
| 21-Hydroxylasemangel (CYP21A2), SNV | 21-Hydroxylasemangel (CYP21A2), SNV | Molecular Diagnostics / PCR |
| Adenosinmonophosphat- Desaminase-Mangel (AMPD1 c.133C>T) | Adenosinmonophosphat- Desaminase-Mangel (AMPD1 c.133C>T) | Molecular Diagnostics / PCR |
| Aderhautmelanom (GNAQ Exon 4/5, GNA11 Exon 4/5, SF3B1 p.Arg625), SNV | Aderhautmelanom (GNAQ Exon 4/5, GNA11 Exon 4/5, SF3B1 p.Arg625), SNV | Molecular Diagnostics / PCR |
| Akute myeloische Leukämie/ | Akute myeloische Leukämie | Molecular Diagnostics / PCR |
| Cowden-Syndrom (PTEN), SNV | Cowden-Syndrom (PTEN), SNV | Molecular Diagnostics / PCR |
| Deletion/Duplication Syndrom | Deletion/Duplication Syndrom | Molecular Diagnostics / PCR |
| DiGeorge; 22q11.2 | DiGeorge; 22q11.2 | Molecular Diagnostics / PCR |
| Ehlers-Danlos-Syndrom (COL3A1, COL5A1, COL5A2, TNXB), SNV | Ehlers-Danlos-Syndrom (COL3A1, COL5A1, COL5A2, TNXB), SNV | Molecular Diagnostics / PCR |
| Ehlers-Danlos-Syndrom (COL3A1, TNXB) | Ehlers-Danlos-Syndrom (COL3A1, TNXB) | Molecular Diagnostics / PCR |
| Entwicklungsstörung | Entwicklungsstörung | Molecular Diagnostics / PCR |
| GJB6) | Schwerhörigkeit (GJB6) | Molecular Diagnostics / PCR |
| HBOC (BRCA1, BRCA2, ATM, BARD1, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53), SNV | HBOC (BRCA1, BRCA2, ATM, BARD1, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53), SNV | Molecular Diagnostics / PCR |
| HBOC (BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D) | HBOC (BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D) | Molecular Diagnostics / PCR |
| HNPCC (MLH1, MSH2, MSH6, PMS2, EPCAM) | HNPCC (MLH1, MSH2, MSH6, PMS2, EPCAM) | Molecular Diagnostics / PCR |
| HNPCC (MLH1, MSH2, MSH6, PMS2, EPCAM), SNV | HNPCC (MLH1, MSH2, MSH6, PMS2, EPCAM), SNV | Molecular Diagnostics / PCR |
| Hereditäre Dystonie (THAP1) | Hereditäre Dystonie (THAP1) | Molecular Diagnostics / PCR |
| Hereditäres Magenkarzinom (CDH1) | Hereditäres Magenkarzinom (CDH1) | Molecular Diagnostics / PCR |
| Hereditäres Magenkarzinom (CDH1), SNV | Hereditäres Magenkarzinom (CDH1), SNV | Molecular Diagnostics / PCR |
| Kleinwuchs (SHOX), SNV | Kleinwuchs (SHOX), SNV | Molecular Diagnostics / PCR |
| LGL (STAT3 Exon 21, STAT5B Exon 15-17), SNV | LGL (STAT3 Exon 21, STAT5B Exon 15-17), SNV | Molecular Diagnostics / PCR |
| Li-Fraumeni-Syndrom (TP53, CHEK2) | Li-Fraumeni-Syndrom (TP53, CHEK2) | Molecular Diagnostics / PCR |
| Li-Fraumeni-Syndrom (TP53, CHEK2), SNV | Li-Fraumeni-Syndrom (TP53, CHEK2), SNV | Molecular Diagnostics / PCR |
| Loeys-Dietz-Syndrom (SMAD3, TGFB2, TGFBR1, TGFBR2), SNV | Loeys-Dietz-Syndrom (SMAD3, TGFB2, TGFBR1, TGFBR2), SNV | Molecular Diagnostics / PCR |
| Marfan Syndrom (FBN1, TGFBR2) | Marfan-Syndrom (FBN1, TGFBR2) | Molecular Diagnostics / PCR |
| Marfan-Syndrom (FBN1, TGFBR2), SNV | Marfan-Syndrom (FBN1, TGFBR2), SNV | Molecular Diagnostics / PCR |
| Multiples Myelom/Plasmozytom | Multiples Myelom/Plasmozytom | Molecular Diagnostics / PCR |
| Myelodysplastisches Syndrom | Myelodysplastisches Syndrom | Molecular Diagnostics / PCR |
| Myelodysplastisches Syndrom (FLT3- -TKD, NPM1 Exon 11) | Myelodysplastisches Syndrom (FLT3- -TKD, NPM1 Exon 11) | Molecular Diagnostics / PCR |
| Myelodysplastisches Syndrom (FLT3- ITD/LM) | Myelodysplastisches Syndrom (FLT3- ITD/LM) | Molecular Diagnostics / PCR |
| Myelodysplastisches Syndrom/ CLL (TP53), SNV | Myelodysplastisches Syndrom/ CLL (TP53), SNV | Molecular Diagnostics / PCR |
| Neurofibromatose (NF1) | Neurofibromatose (NF1) | Molecular Diagnostics / PCR |
| Neurofibromatose (NF1), SNV | Neurofibromatose (NF1), SNV | Molecular Diagnostics / PCR |
| Noonan-Syndrom (PTPN11, SOS1, RAF1, RIT1, BRAF, KRAS), SNV | Noonan-Syndrom (PTPN11, SOS1, RAF1, RIT1, BRAF, KRAS), SNV | Molecular Diagnostics / PCR |
| Pankreaskarzinom (BRCA1, BRCA2, CDKN2A, STK11, PALB2, ATM, CHEK2, APC, TP53, MLH1, MSH2, MSH6, PMS2, EPCAM, VHL) | Pankreaskarzinom (BRCA1, BRCA2, CDKN2A, STK11, PALB2, ATM, CHEK2, APC, TP53, MLH1, MSH2, MSH6, PMS2, EPCAM, VHL) | Molecular Diagnostics / PCR |
| Parkinson (PARK2, SNCA, PINK1, UCHL1, PARK7, ATP13A2, LRRK2) | Parkinson (PARK2, SNCA, PINK1, UCHL1, PARK7, ATP13A2, LRRK2) | Molecular Diagnostics / PCR |
| Peutz-Jeghers-Syndrom (STK11), SNV | Peutz-Jeghers-Syndrom (STK11), SNV | Molecular Diagnostics / PCR |
| Polyposis, adenomatös: FAP / MAP | Polyposis, adenomatös: FAP, MAP | Molecular Diagnostics / PCR |
| Polyposis, juvenil: JPS (BMPR1A, SMAD4) | Polyposis, juvenil: JPS (BMPR1A, SMAD4), SNV | Molecular Diagnostics / PCR |
| Prostatakarzinom (BRCA1, BRCA2, CHEK2, PALB2, ATM) | Prostatakarzinom (BRCA1, BRCA2, CHEK2, PALB2, ATM) | Molecular Diagnostics / PCR |
| Prostatakarzinom (BRCA1, BRCA2, CHEK2, PALB2, ATM), SNV | Prostatakarzinom (BRCA1, BRCA2, CHEK2, PALB2, ATM), SNV | Molecular Diagnostics / PCR |
| RNU4-2 assoziierte | RNU4-2 assoziierte | Molecular Diagnostics / PCR |
| Rett-Syndrom (MECP2) | Rett-Syndrom (MECP2) | Molecular Diagnostics / PCR |
| Rett-Syndrom (MECP2), SNV | Rett-Syndrom (MECP2), SNV | Molecular Diagnostics / PCR |
| Sotos-Syndrom (NSD1), SNV | Sotos-Syndrom (NSD1), SNV | Molecular Diagnostics / PCR |
| Spinocerebelläre Ataxien (SCA 1, 2, 3, 4, 6, 7, 8, 10, 12, 17) | Spinocerebelläre Ataxien (SCA 1, 2, 3, 4, 6, 7, 8, 10, 12, 17) | Molecular Diagnostics / PCR |
| Standort: Albert-Schweitzer-Campus | Standort: Albert-Schweitzer-Campus | Molecular Diagnostics / PCR |
| Tumorpanel (APC, ATM, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, FH, MBD4, MLH1, MSH2, MSH3, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS2, POLD1, POLE, PTCH1, PTCH2, PTEN, RAD51C, RAD51D, SMAD4, STK11, SUFU, TP53, VHL), SNV | Tumorpanel (APC, ATM, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, FH, MBD4, MLH1, MSH2, MSH3, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS2, POLD1, POLE, PTCH1, PTCH2, PTEN, RAD51C, RAD51D, SMAD4, STK11, SUFU, TP53, VHL), SNV | Molecular Diagnostics / PCR |
| Whole Genome Sequencing (SNVs, CNVs, SV und Repeats) | Whole Genome Sequencing (SNVs, CNVs, SV und Repeats) | Molecular Diagnostics / PCR |
| AITL (TET2, DNMT3A, RHOA p.Gly17, IDH2 p.Arg172), , SNV | AITL (TET2, DNMT3A, RHOA p.Gly17, IDH2 p.Arg172), , SNV | Other |
| Akute myeloische Leukämie (NPM1, | Akute myeloische Leukämie (NPM1, | Other |
| CLL (TP53, NOTCH1 Exon 34, SF3B1 Exon 13-16, BIRC3, MYD88 p.Leu265Pro), SNV | CLL (TP53, NOTCH1 Exon 34, SF3B1 Exon 13-16, BIRC3, MYD88 p.Leu265Pro), SNV | Other |
| CMML (TET2, ASXL1 Exon 13, SRSF2 Exon 1, RUNX1, NRAS, KRAS, SETBP1), SNV | CMML (TET2, ASXL1 Exon 13, SRSF2 Exon 1, RUNX1, NRAS, KRAS, SETBP1), SNV | Other |
| DLBCL (TP53, EZH2, CD79B, CARD11, MYD88 p.Leu265Pro), SNV | DLBCL (TP53, EZH2, CD79B, CARD11, MYD88 p.Leu265Pro), SNV | Other |
| Myeloproliferative Neoplasie (JAK2 p.Val617Phe und Exon 12, CALR Exon 9, MPL Exon 10), SNV | Myeloproliferative Neoplasie (JAK2 p.Val617Phe und Exon 12, CALR Exon 9, MPL Exon 10), SNV | Other |
| Primäre Myelofibrose (JAK2, CALR, MPL, TET2, ASXL1, EZH2, DNMT3A, IDH1, IDH2, SRSF2, SF3B1, U2AF1, ZRSR2, CBL, KRAS, NRAS, STAG2, TP53), SNV | Primäre Myelofibrose (JAK2, CALR, MPL, TET2, ASXL1, EZH2, DNMT3A, IDH1, IDH2, SRSF2, SF3B1, U2AF1, ZRSR2, CBL, KRAS, NRAS, STAG2, TP53), SNV | Other |
| a Die Proben werden vom Labor ohne vorherige histologische Beurteilung | a Die Proben werden vom Labor ohne vorherige histologische Beurteilung | Other |
| p.Arg132 und IDH2 p.Arg140 und p.Arg172), , SNV | p.Arg132 und IDH2 p.Arg140 und p.Arg172), , SNV | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.